Luxor Scientific offers a variety of tests to help women manage their specific health needs no matter where they are in life, including fertility, pregnancy, and mid-life hormone testing.
Women’s Health
Unique support for every stage of a woman’s life
Our comprehensive women’s wellness testing can give healthcare providers the information they need to help their patients to take ownership of their own health.
- Cortisol
- Dehydroepiandrosterone (DHEA)
- Estradiol
- Follicle-Stimulating Hormone (FSH)
- Free T3 (triiodothyronine)
- Free T4 (thyroxine)
- Human Chorionic Gonadotropin (hCG)
- Luteinizing Hormone (LH)
- Progesterone
- Thyroid Peroxidase Antibodies
- Thyroid-Stimulating Hormone
- Total Testosterone
Luxor Scientific’s results provide answers so you can take informed action towards your patient’s health. Molecular tests provide greater sensitivity and specificity ensuring accurate diagnosis each time.
- Atopobium vaginae
- BVAB2
- Candida albicans
- Candida glabrata
- Candida parapsilosis
- Candida tropicalis
- Enterococcus faecalis
- Escherichia coli
- Gardnerella vaginalis
- Lactobacillus crispatus
- Lactobacillus iners
- Lactobacillus jensenii
- Megasphaera type 1
- Megasphaera type 2
- Mycoplasma hominis
- Staphylococcus aureus
- Streptococcus agalactiae
- Ureaplasma urealyticum
Our PCR-based methods rapidly detect all of the most common STIs with a noninvasive urine specimen or a traditional swab.
- Chlamydia trachomatis
- Haemophilus ducreyi
- Herpes simplex 1
- Herpes simplex 2
- Mycoplasma genitalium
- Mycoplasma hominis
- Neisseria gonorrhoeae
- Treponema pallidum
- Trichomonas vaginalis
- Ureaplasma urealyticum
PCR-based testing using molecular technology provides reliable and actionable results with a rapid turnaround time.
- Candida glabrata
- Candida parapsilosis
- Candida tropicalis
- Enterobacter cloacae
- Enterococcus faecalis
- Escherichia coli
- Klebsiella oxytoca
- Klebsiella pneumoniae
- Morganella morganii
- Mycoplasma hominis
- Proteus mirabilis
- Providencia stuartii
- Pseudomonas aeruginosa
- Serratia marcescens
- Staphylococcus aureus
- Staphylococcus saprophyticus
- Streptococcus agalactiae (GBS)
- Ureaplasma urealyticum
The prevalence of high-risk HPV genotypes, beyond genotypes 16 and 18, have greatly increased over the past few years because they are not associated with existing vaccines. Persistent infections with these additional high-risk genotypes (31, 33, and 51), are associated with cervical, vaginal, vulvar, and head and neck malignancies.
Extended genotyping enables risk stratification and persistence monitoring to reduce the risk that individuals progress to cervical cancer. For this reason, Luxor Scientific was one of the first laboratories in our region to offer testing for additional high-risk HPV genotypes beyond genotypes 16 and 18.